Angelo Passanante

Angelo Passanante serves as Ceo at aptiva medical srl. aptiva medical srl operates in the medical devices sector with approximately 26.0 employees. The company is headquartered in Milan, Lombardy.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • We have verified contacts for 2 executives at aptiva medical srl.
• • 1,717 executive contacts are available in Lombardy.
• • Our database includes 201,464 c suite-level executives.

Outlook Amadesa Google Tag Manager Woo Commerce WordPress.org Google Maps Google Analytics Mobile Friendly Micro Render Remote Circle AI

medical equipment manufacturing medical distribution patient care innovative technologies clinical assistance public hospitals private hospitals healthcare solutions surgical instruments pain relief life extension cardiovascular surgeries thoracic surgeries electrophysiology neurosurgery spine surgery general surgery urology gastroenterology transport systems biological materials medical electrodes surgical patches wound closure systems clinical training customer support market analysis sales strategy medical regulations logistics services key opinion leaders event organization medical conferences surgical equipment personalized solutions eye glasses surgical glasses light sources led surgical lights optical precision custom lenses surgical lighting video recording devices durability thermal protection battery life brightness levels illumination technology equipment customization repair services medical devices hospital & health care

PP

Paolo Pica CEO at aptiva medical srl

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Angelo Passanante in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at aptiva medical srl.

Angelo Passanante's Position in the MessageCEO Database

• •Angelo Passanante is 1 of 2 verified executive contacts we track at aptiva medical srl.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •1,706 verified executive contacts in Lombardy are in the database.
• •23 verified contacts work at medical devices companies in the 26.0 employee range (same size as aptiva medical srl).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated November 2026.

How do I reach Angelo Passanante directly?

Angelo Passanante's verified email address is available to MessageCEO Pro subscribers. They currently serve as Ceo at aptiva medical srl. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Angelo Passanante work for?

Angelo Passanante is Ceo at aptiva medical srl, a company in the medical devices sector with 26.0 employees. The company is based in Milan, Lombardy.

Can I pitch or sell to Angelo Passanante?

As Ceo at aptiva medical srl, Angelo Passanante is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Angelo Passanante directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Angelo Passanante in?

Angelo Passanante works in the medical devices industry as Ceo at aptiva medical srl. MessageCEO provides verified contact information for executives across all major industries.

Is Angelo Passanante's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Angelo Passanante's profile is kept up-to-date with the latest available information.

Last updated: November 5, 2026